A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 31/40 (2006.01) A61P 3/06 (2006.01)
Patent
CA 2621134
The present invention relates to improved pharmaceutical formulation for oral administration comprising a therapeutically effective quantity of an HMG-CoA reductase inhibitor, and more particularly Fluvastatin, Atorvastatin or salts thereof in combination with a linear sulphated polysaccharide such as Carrageenan and a method for the preparation thereof.
La présente invention concerne une formulation pharmaceutique améliorée pour administration orale, ladite formulation pharmaceutique comprenant une quantité thérapeutiquement efficace d'un inhibiteur de la HMG-CoA réductase, et plus particulièrement la fluvastatine, l'atorvastatine ou leurs sels, en combinaison avec un polysaccharide sulfaté linéaire tel que la carragénine. L'invention concerne également un procédé de préparation de ladite formulation pharmaceutique.
Bikiaris Dimitrios
Ioannidou Elisavet
Karavas Evangelos
Koutris Efthimios
Stathaki Eleni
Moffat & Co.
Pharmathen S.a.
LandOfFree
Pharmaceutical formulation containing an hmg-coa reductase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulation containing an hmg-coa reductase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation containing an hmg-coa reductase... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1382210